Follow the people · Insider

AG

Andrew Guggenhime

Insider · President and CFO · PCVX

Andrew Guggenhime files insider transactions with the SEC as a president and cfo of Vaxcyte (PCVX). We hold 3 disclosed purchases and sales filed since 13 January 2006, 3 of them in the last 90 days.

  • Files forPCVX
  • Disclosed buys and sells3 in all, 3 in the last 90 days
  • Last disclosure2 September 2026

Positions held

7 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 April 20212 September 2026President and CFO · Vaxcyte (PCVX)187 Form 4 lines · source: SEC Form 4
  • Filed 20 December 202120 February 2026Director · Caribou Biosciences (CRBU)6 Form 4 lines · source: SEC Form 4
  • Filed 24 May 202118 May 2022Director · Metacrine (MTCR)2 Form 4 lines · source: SEC Form 4
  • Filed 2 October 201420 February 2020CFO · Dermira (DERM)73 Form 4 lines · source: SEC Form 4
  • Filed 23 January 200921 April 2010SVP & CFO · Facet Biotech (FACT)13 Form 4 lines · source: SEC Form 4
  • Filed 3 April 200618 December 2008SVP & Chief Financial Officer · Pdl Biopharma (PDLI)8 Form 4 lines · source: SEC Form 4
  • Filed 29 July 200529 July 2005Chief Financial Officer · Neoforma (NEOF)1 Form 4 line · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.